Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multi-center Open-label Phase 2 Study of Ixazomib, Iberdomide and Dexamethasone in Elderly Patients With Multiple Myeloma at First Relapse."

NCT04998786 is registered in ClinicalTrials.gov with Nantes University Hospital as lead sponsor.

NCT NCT04998786
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04998786 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multi-center Open-label Phase 2 Study of Ixazomib, Iberdomide and Dexamethasone in Elderly Patients With Multiple Myeloma at First Relapse."
Lead sponsor
Nantes University Hospital
Phase
Phase 2
Overall status
Active, not recruiting
Start date
December 14, 2021
Completion date
January 1, 2030
Enrollment
75 (actual)
Sites
21

Conditions

As the registry lists them; a condition with its own page is linked.

multiple myeloma at first relapse